Dataset Information

Epigenetic evidence of an Ac/Dc axis by VPA and SAHA

ABSTRACT: Epigenetic evidence of an Ac/Dc axis by VPA and SAHA

PROVIDER: PRJNA1156691 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	SRR30545810.fastq.gz	Fastqsanger.gz
	SRR30545811.fastq.gz	Fastqsanger.gz
	SRR30545812.fastq.gz	Fastqsanger.gz
	SRR30545813.fastq.gz	Fastqsanger.gz
	SRR30545814.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 21

Similar Datasets

Project description:BackgroundValproic acid (VPA) is one of the most commonly used anti-epileptic drugs with pharmacological actions on GABA and blocking voltage-gated ion channels. VPA also inhibits histone deacetylase (HDAC) activity. Suberoylanilide hydroxamic acid is also a member of a larger class of compounds that inhibit HDACs. At the time of this article, there are 123 active international clinical trials for VPA (also known as valproate, convulex, divalproex, and depakote) and SAHA (vorinostat, zolinza). While it is well known that VPA and SAHA influence the accumulation of acetylated lysine residues on histones, their true epigenetic complexity remains poorly understood.ResultsPrimary human cells were exposed to VPA and SAHA to understand the extent of histone acetylation (H3K9/14ac) using chromatin immunoprecipitation followed by sequencing (ChIP-seq). Because histone acetylation is often associated with modification of lysine methylation, we also examined H3K4me3 and H3K9me3. To assess the influence of the HDAC inhibitors on gene expression, we used RNA sequencing (RNA-seq). ChIP-seq reveals a distribution of histone modifications that is robust and more broadly regulated than previously anticipated by VPA and SAHA. Histone acetylation is a characteristic of the pharmacological inhibitors that influenced gene expression. Surprisingly, we observed histone deacetylation by VPA stimulation is a predominant signature following SAHA exposure and thus defines an acetylation/deacetylation (Ac/Dc) axis. ChIP-seq reveals regionalisation of histone acetylation by VPA and broader deacetylation by SAHA. Independent experiments confirm H3K9/14 deacetylation of NFκB target genes by SAHA.ConclusionsThe results provide an important framework for understanding the Ac/Dc axis by highlighting a broader complexity of histone modifications by the most established and efficacious anti-epileptic medication in this class, VPA and comparison with the broad spectrum HDAC inhibitor, SAHA.

Dataset Information

Epigenetic evidence of an Ac/Dc axis by VPA and SAHA

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets